Berentzen-Gruppe (BEZ) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
25 Dec, 2025Executive summary
Consolidated revenues for 2024 were EUR 181.9 million, down 2.0% year-over-year due to market challenges, inflation, and the sale of the Grüneberg site.
Despite lower revenues, consolidated EBITDA rose by 20.7% to EUR 19.3 million and EBIT by 37.0% to EUR 10.6 million, reaching the highest EBIT in years, driven by improved gross profits and product margins.
The sale of the Grüneberg site led to a one-off negative net profit effect of EUR 4.8 million and a net loss of EUR 1.25 million, but is expected to improve long-term EBIT and liquidity.
Free cash flow remained positive, supporting a proposed dividend of EUR 0.11 per share despite the net loss.
Financial highlights
Gross profit margin increased by 300 basis points year-over-year, rising from 41.5% to 44.5%, with gross profit up 4.1% to EUR 80.4 million.
Net profit was negative at EUR 1.3 million, mainly due to exceptional effects and high interest expenses.
Operating cash flow improved to EUR 12.6 million, and free cash flow turned positive at EUR 2.7 million after two years of negative results.
Dividend proposal of EUR 0.11 per share despite negative net profit, supported by positive free cash flow.
EBIT margin improved to 5.8% from 4.1%.
Outlook and guidance
2025 revenue forecast: EUR 180–190 million, with underlying growth when adjusted for the Grüneberg sale.
EBITDA expected at EUR 19–21 million and EBIT at EUR 10–12 million for 2025.
Significant increase in marketing spend to EUR 5 million in 2025, aiming for double-digit growth in key brands.
Double-digit growth expected for Mio Mio and Minis segments in 2025.
Dividend proposal reflects confidence in future development despite current-year loss.
Latest events from Berentzen-Gruppe
- Profitability surged in H1 2024 despite flat sales, with Grüneberg divestment set to lift margins.BEZ
Q2 20241 Feb 2026 - Revenue and profit declined year-over-year; outlook lowered amid challenging market conditions.BEZ
Q3 202523 Oct 2025 - Revenue and earnings declined, but profit turned positive and outlook remains cautiously optimistic.BEZ
Q2 202514 Aug 2025 - Adjusted EBIT and EBITDA surged despite stable revenues and one-off impairment losses.BEZ
Q3 202413 Jun 2025 - Revenue down 4.7% in Q1 2025; outlook for full year remains positive despite market volatility.BEZ
Q1 20255 Jun 2025